Schedule 13G ownership disclosure
LB Pharmaceuticals Inc
Common Stock · CUSIP: 50180M108
Event date: 2025-12-31
- Filing-level shares
- 961,158
- Percent of class
- 3.8%
- BlackRock Portfolio Management LLC
Shares: 961,158 · Class: 3.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-26-000189
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock Portfolio Management LLC
- CIK
- CIK 2052113
- Filed
- Jan 21, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership